Full-Time

Senior Director

Clinical Scientist

Confirmed live in the last 24 hours

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines and therapies

Biotechnology
Healthcare

Senior, Expert

Cambridge, MA, USA + 1 more

More locations: Princeton, NJ, USA

70% in-office work model.

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Required Skills
Data Analysis
Requirements
  • Advanced Degree in a Scientific discipline (i.e. M.S, Ph.D. or Pharm.D.) is required.
  • A minimum of 10 years of clinical research and development, or related experience within the industry (pharmaceutical, biotech, CRO, etc.) is required.
  • The individual must have demonstrated ability to lead a team; track record of building a team is a plus.
  • Extensive experience in Therapeutics Development – Oncology or Rare disease experience preferred, and across different therapeutic areas is a plus.
  • Track record of successfully managing pivotal phase 3 programs, including registrational database locks; submission and HA inspection experience is a plus.
  • Experience with CRO oversight.
  • Track record of leading development and implementation of new processes and roles.
  • Track record of working with a diverse cross functional team, with ability to influence and align with key cross functional stakeholders.
  • Proven leadership in clinical evaluation projects, including the development of protocols, case report forms, informed consent, study initiation, and monitoring.
  • Exceptional abilities in data integrity, exploration, analysis, and presentation.
  • Excellent written communication, oral communication, and presentation skills are required.
  • Ability to travel up to 30% is required.
Responsibilities
  • Establish Clinical Sciences as a valued scientific leadership line function
  • Hire, onboard, train, mentor, develop, and manage a high-functioning group of clinical scientists that are seen as valued scientific partners in the design and execution of clinical programs
  • Partner with critical Functional Line Leaders (Study Physicians, Clinical Operations, Biometrics, Safety) to define cross-functional ways of working with Clinical Sciences
  • Setup ways of working, standards, and tools for Clinical Scientists to ensure clinical relevancy and interpretability of data through the authorship of core study documents (e.g., protocols, informed consent forms, eCRFs) and the creation & execution of critical study plans (e.g., medical monitoring and data cleaning plans)
  • Serve as point of contact and escalation for setting up and managing outsourced scopes of work to Contract Research Organizations through partnership with Development Operations
  • Serve as the accountable person for the quality of clinical trial data for clinical review and interpretation to achieve regulatory reporting/filing milestones
  • Partner across development line functions to deliver well executed clinical programs
  • Partner with Program and Clinical Leadership to plan and resource clinical programs effectively
  • Oversee the quality and effectiveness of the Clinical Scientist Team, including their: Collaboration with Clinical Operations, Study Team & Program Leadership in the planning and execution of clinical studies, Effective Scientific Authorship of protocols, consent forms, analysis plans and other key scientific study documents, Timely and High-Quality Data Review of data listings, data coding, cohort profiles, and analyses, Coordination of clinical and safety oversight by Study Physicians and Pharmacovigilance to ensure study treatment discontinuation or other safety decisions are made per protocol, Oversight of database, Delivery of Relevant and Timely Data Analyses, Reporting & Presentation to meet timelines for investigator & monitoring committee meetings, regulatory actions, and to make timely program decisions regarding study objectives, Planning and Execution of Protocol/Scientific Training of Investigators, Site Management/Monitors, and other key study personnel, Facilitation of scientific content and discussion for Advisory Board / Scientific Committee Meetings, and with Investigators and Site Study Staff throughout the lifecycle of the program
  • Serve as a Clinical Scientist to address study demands as needed, acting as player coach, taking on study level responsibility as needed

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a molecule that provides instructions for cells to produce proteins essential for various biological functions. Their approach involves creating a new class of medicines that leverage mRNA to potentially enhance the discovery, development, and manufacturing of drugs. Unlike traditional methods, which often rely on proteins or other biological materials, Moderna's use of mRNA allows for a more versatile and efficient way to create treatments. The company's goal is to improve patient outcomes by harnessing the power of mRNA to address a wide range of health issues.

Company Stage

Grant

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

N/A

Growth & Insights
Headcount

6 month growth

3%

1 year growth

12%

2 year growth

54%
Simplify Jobs

Simplify's Take

What believers are saying

  • Moderna's expansion into combination vaccines and autoimmune therapies showcases its potential for diversified revenue streams and market leadership.
  • The company's continuous innovation and FDA approvals for updated COVID-19 vaccines highlight its resilience and adaptability in a rapidly changing market.
  • Moderna's educational initiatives, like the free mRNA course, position it as a thought leader and advocate for mRNA technology.

What critics are saying

  • The collapse in demand for COVID-19 vaccines could significantly impact Moderna's revenue and growth prospects.
  • Ongoing class action lawsuits alleging securities fraud could damage Moderna's reputation and financial stability.

What makes Moderna unique

  • Moderna is pioneering the use of mRNA technology to create a new class of medicines, setting it apart from traditional pharmaceutical companies.
  • The company's focus on mRNA as the 'software of life' allows for rapid development and manufacturing of vaccines and therapies, unlike conventional methods.
  • Moderna's ability to secure regulatory approvals for mRNA vaccines beyond COVID-19, such as for RSV, demonstrates its leadership in mRNA technology.

Help us improve and share your feedback! Did you find this helpful?